Adaptive Biotechnologies
ADPT
ADPT
206 hedge funds and large institutions have $5.41B invested in Adaptive Biotechnologies in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 96 increasing their positions, 43 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
206
Holders Change
+10
Holders Change %
+5.1%
% of All Funds
4.17%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
39
Increased
96
Reduced
43
Closed
28
Calls
$20.2M
Puts
$5.31M
Net Calls
+$14.9M
Net Calls Change
+$7.88M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BCV
226
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| – | -$33K | -686 | Closed |
|
227
First Manhattan
New York
| – | -$31K | -650 | Closed |
|
|
CAN
228
Cetera Advisor Networks
El Segundo,
California
| – | -$28K | -575 | Closed |
|
|
QI
229
QS Investors
New York
| – | -$15K | -300 | Closed |
|
|
SWM
230
Sugarloaf Wealth Management
Duluth,
Georgia
| – | -$5K | -100 | Closed |
|
|
S
231
SignatureFD
Atlanta,
Georgia
| – | -$2K | -45 | Closed |
|
|
OPS
232
Orion Portfolio Solutions
Omaha,
Nebraska
| – | -$2K | -41 | Closed |
|